| Symbol | Company | Weighting |
|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP USD | 6.64% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 4.48% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 3.82% |
| ARGX | ARGENX SE ADR | 3.56% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 3.48% |
| IONS | IONIS PHARMACEUTICALS INC | 3.45% |
| NTRA | NATERA INC | 3.40% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 3.27% |
| TARS | TARSUS PHARMACEUTICALS | 3.23% |
| MCK | MCKESSON CORP | 2.68% |
| HCA | HCA HOLDINGS INC | 2.51% |
| NUVL | NUVALENT INC | 2.46% |
| ALKS | ALKERMES INC | 2.34% |
| AZN | ASTRAZENECA PLC | 2.20% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 2.02% |
| ISRG | INTUITIVE SURGICAL INC | 2.01% |
| CYTK | CYTOKINETICS INC | 1.85% |
| IDXX | IDEXX LABS CORP | 1.81% |
| AMGN | AMGEN CORP | 1.77% |
| SYK | STRYKER CORP | 1.74% |
| LNTH | LANTHEUS HOLDINGS INC | 1.73% |
| APLS | APELLIS PHARMACEUTICALS INC | 1.66% |
| DNLI | DENALI THERAPEUTICS INC. | 1.64% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.63% |
| SNY | SANOFI- AVENTIS- ADR | 1.63% |
| LLY | ELI LILLY CORP | 1.61% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.57% |
| MRK | MERCK & CO. NEW | 1.50% |
| EW | EDWARDS LIFESCIENCES CORP | 1.48% |
| IMVT | IMMUNOVANT INC | 1.45% |
| BSX | BOSTON SCIENTIFIC | 1.41% |
| PCVX | VAXCYTE INC | 1.39% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.34% |
| REGN | REGENERON PHARMACEUTICALS | 1.30% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.24% |
| DHR | DANAHER CORP | 1.24% |
| BIIB | BIOGEN INC | 1.24% |
| DYN | DYNE THERAPEUTICS, INC. | 1.19% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.19% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.16% |
| ZTS | ZOETIS INC | 1.13% |
| BDX | BECTON DICKINSON & CO | 1.07% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 0.98% |
| UNH | UNITEDHEALTH GROUP INC | 0.97% |
| ELV | ELEVANCE HEALTH INC | 0.97% |
| XNCR | XENCOR INC. | 0.90% |
| VKTX | VIKING THERAPEUTICS, INC. | 0.88% |
| DXCM | DEXCOM INC | 0.79% |
| TNDM | TANDEM DIABETES CARE INC | 0.75% |
| KURA | KURA ONCOLOGY INC | 0.69% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.67% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 0.61% |
| ARVN | ARVINAS INC USD | 0.56% |
| AVTR | AVANTOR, INC. | 0.55% |
| NVO | NOVO NORDISK A/S | 0.49% |
| WAT | WATERS CORP | 0.31% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.28% |
| RNA | ATRIUM THERAPEUTICS INC | 0.08% |
| AKROCV | CONTRA AKERO THERAPEUT | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.